Skip to search formSkip to main contentSkip to account menu

dendritic cell vaccine

Known as: cell dendritic vaccines, cells dendritic vaccine 
A vaccine made of antigens and dendritic antigen-presenting cells (APCs).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Dendritic cell (DC) ‐based cancer immunotherapy is one of the most important anti‐cancer immunotherapies, and has been associated… 
2013
2013
Patients with relapsed stage 4 neuroblastoma have an extremely poor long-term prognosis, making the investigation of new agents… 
Highly Cited
2012
Highly Cited
2012
BackgroundDendritic cells (DCs) could be used as potential cellular adjuvant for the production of specific tumor vaccines… 
2012
2012
Active immunotherapy and cancer vaccines that promote host antitumor immune responses promise to be effective and less toxic… 
Highly Cited
2011
Highly Cited
2011
The immunostimulatory capacity of dendritic cells is improved by co-electroporation with mRNA encoding CD40 ligand… 
2007
2007
Cancer vaccine therapy represents a promising therapeutical option. Consistently, with these new treatment strategies, the use of… 
Highly Cited
2006
Highly Cited
2006
Dendritic cells (DC) are professional antigen-presenting cells that play a pivotal role in the induction of immunity. Ex vivo… 
Highly Cited
2006
Highly Cited
2006
Survivin is a member of the inhibitor of apoptosis protein family. Gliomas and many other tumors express survivin at high levels… 
2004
2004
Here we describe the effect of immunization with dendritic cells loaded with syngeneic tumor cells (DC/Ts) by polyethylene glycol… 
Highly Cited
2000
Highly Cited
2000
The unique Ag-presenting capabilities of dendritic cells (DCs) make them attractive vehicles for the delivery of therapeutic…